U.S. Gas Utilities Stock News

NYSE:CQP
NYSE:CQPOil and Gas

Cheniere Energy Partners (CQP) Prices $2b Notes, Is The Current Valuation Fully Valued?

Cheniere Energy Partners (CQP) recently priced a $2 billion senior notes offering in two long-dated tranches, with proceeds earmarked for debt refinancing, capital expenditures, and its Sabine Pass LNG expansion contract with Bechtel. See our latest analysis for Cheniere Energy Partners. At a share price of $61.93, Cheniere Energy Partners has seen a 1-day share price return of 0.96% and a year to date share price return of 14.69%. Its 1-year total shareholder return of 18.40% and 5-year...
NYSE:AJG
NYSE:AJGInsurance

Arthur J. Gallagher (AJG) Leaves Russell Growth Indexes, Is The Stock Too Pricey?

Index changes put Arthur J. Gallagher back in focus Arthur J. Gallagher (AJG) has just been removed from several Russell growth benchmarks and added to the Russell 1000 Dynamic Index, a reshuffle that can prompt index-tracking funds to adjust positions. See our latest analysis for Arthur J. Gallagher. Against this index reshuffle backdrop, Arthur J. Gallagher’s share price has shown short term strength, with a 7 day share price return of 9.97% and 30 day share price return of 15.56%. At the...
NYSE:ZETA
NYSE:ZETASoftware

Is Zeta Global Holdings (ZETA) Undervalued Following Its Palantir AI Partnership?

Why Zeta Global’s AI Partnership With Palantir Matters For Investors Zeta Global Holdings (ZETA) recently announced a partnership with Palantir Technologies to rebuild its Data Cloud on Palantir Foundry, tightly linking Athena by Zeta with Palantir’s enterprise AI infrastructure. This technical integration is designed to connect operational intelligence, customer data, and marketing execution in one environment, a shift that could influence how investors think about Zeta Global’s role in...
NYSE:IVZ
NYSE:IVZCapital Markets

Is Invesco (IVZ) Undervalued Following Its Northern Trust Fund Range Appointment?

Invesco (IVZ) has drawn fresh attention after appointing Northern Trust to support its new Irish domiciled index tracking mutual fund range. This move arrives alongside steady dividends and recently stable earnings results. See our latest analysis for Invesco. The partnership with Northern Trust comes as Invesco stock trades at $27.83, with a 90 day share price return of 22.22% and a 1 year total shareholder return of 72.28%. This suggests momentum has been building over both shorter and...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

Is FCPT’s Latest Arby’s and Medical Deals Refining Its Core Net‑Lease Strategy?

Four Corners Property Trust recently expanded its portfolio by acquiring two Arby's properties in Indiana and Kentucky for US$3.4 million and a Springfield Clinic property in Illinois for US$3.5 million, all under long-term triple net leases with remaining terms of about seven to 15 years and cap rates around 6.7–6.8%. These acquisitions highlight FCPT's push into essential, e‑commerce‑resistant retail and medical assets, reinforcing its focus on stable, lease-driven rental income. We’ll now...
NYSE:KO
NYSE:KOBeverage

PepsiCo Stock And 2 Consumer Staples Picks For Sticky Inflation

With inflation picking up across the OECD, led by a sharp rise in energy costs and steady core inflation at 3.8%, many investors are rethinking how to position their portfolios for stubborn price pressures. Consumer staples stocks, especially larger food, beverage, and household product companies, can sometimes offer a different mix of resilience and risk when inflation stays elevated. This article looks at three stocks from our Consumer Staples Stocks screener that appear positively exposed...
NYSE:AOS
NYSE:AOSBuilding

Is Leadership Consolidation and Restructuring Altering The Investment Case For A. O. Smith (AOS)?

A. O. Smith Corporation announced that, effective July 1, 2026, longtime leader Kevin J. Wheeler retired as Executive Chairman and remained on the Board, while President and CEO Stephen M. Shafer also assumed the role of Chairman, consolidating the company’s top leadership roles. This leadership transition arrives as A. O. Smith prepares for upcoming earnings amid price increases and restructuring aimed at addressing demand and cost pressures across its water heating and treatment...
NasdaqGM:MDB
NasdaqGM:MDBIT

Will Broader Vector Search Access Across Atlas and On‑Premises Environments Change MongoDB's (MDB) Narrative

In late June 2026, MongoDB announced at MongoDB.local Bengaluru that its Search and Vector Search capabilities, hybrid search, and native AI reranking are now broadly available across Atlas, Enterprise Advanced, and the free Community Edition, extending advanced retrieval tools to on-premises, private cloud, and local environments. This move directly targets two common reasons enterprise AI projects stall, unreliable retrieval quality and compliance constraints, by letting organizations...
NYSE:JBL
NYSE:JBLElectronic

Is Jabil (JBL) Fully Priced As Index Removal And India Expansion Reshape Its Story?

Why Jabil Is Back in Focus After Index Removal and India Expansion Jabil (JBL) is in the spotlight after being removed from multiple Russell indexes while at the same time expanding its manufacturing footprint in India, a combination that has sharpened attention on the stock. The index changes, India build out, insider selling and concerns about how valuation tools view Jabil have all landed within weeks of a change in its earnings outlook from some analysts. This gives investors several...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex (CGNX) OneVision Launch Raises The Question Of Whether The Stock Is Fully Valued

Cognex (CGNX) is back in focus after coverage around its new OneVision platform, which supports AI-based inspection across factories, and growing attention on whether the stock’s valuation premium is justified. See our latest analysis for Cognex. The recent OneVision launch and media attention have arrived alongside sharp share price moves. Cognex’s 30-day share price return of 11.48% and 90-day share price return of 31.17% have contributed to an 83.59% year-to-date share price return, while...
NYSE:STE
NYSE:STEMedical Equipment

STERIS (STE) Faces Renewed Valuation Debate, Is Its Quality Enough To Justify The Price?

STERIS (STE) is back in the spotlight after a period of share weakness and renewed debate about whether its current valuation matches its steady cash flow and consistent healthcare service demand. See our latest analysis for STERIS. At the latest share price of $218.20, STERIS has seen a 1-day share price return of 2.78% and modest gains over the past month, while the year-to-date share price return is down 12.73% and the 1-year total shareholder return is down 5.49%. This continues to focus...
NYSE:SR
NYSE:SRGas Utilities

Spire (SR) Dividend Raise Keeps Fair Value In Focus

Spire (SR) has drawn fresh attention after its board approved an increase in the annual common stock dividend to $3.14 per share from $3.02, extending a 22 year streak of dividend raises. See our latest analysis for Spire. Spire’s share price has been under pressure recently, with the stock down 16.3% on a 90 day share price return basis and 4.8% over the past month. However, the 1 year total shareholder return of 10.4% and 3 year total shareholder return of 42.3% point to stronger longer...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

WD-40 (WDFC) Faces A Margin Test, Is The Upside Already Priced In?

Wall Street’s focus on WD-40 (WDFC) has sharpened ahead of fiscal Q3 2026, as analysts project 10.1% revenue growth alongside flat earnings per share of $1.56, putting gross margin resilience under scrutiny. See our latest analysis for WD-40. WD-40’s share price has climbed to $245.83, with a 30-day share price return of 20.87% and a year-to-date share price return of 24.94%. The 1-year total shareholder return of 8.96% points to stronger recent momentum than longer term. If the recent move...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Global pharma is back in the political spotlight, as US pressure on drug prices abroad collides with European cost controls and fresh trade tensions. For investors, this mix of policy risk and pricing shifts could change how large pharmaceutical stocks are viewed, especially those with significant US and European exposure. This article looks at three large-cap global pharmaceutical companies from our screener that appear especially exposed to the latest headlines, and explains why some...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

How SBA’s Exit From Russell Defensive Indexes Will Impact SBA Communications (SBAC) Investors

In late June 2026, SBA Communications Corporation (NasdaqGS: SBAC) was removed from both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, altering its footprint in key factor-based benchmarks that many institutional investors track. This dual index removal can affect passive fund holdings and may prompt active investors to reassess how SBA Communications fits within defensive and value-oriented portfolios. We’ll now explore how SBA’s removal from these Russell...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Stock And 2 Penny Stocks With Stronger Financial Health

Penny stocks often get attention for the wrong reasons, but the Financially Fit Penny Stocks screener aims to highlight a very different corner of this market: smaller companies trading below 5 that still show solid financial health. With investors watching global growth signals, inflation paths, central bank moves and energy prices, many are looking for ways to stay exposed to potential upside while trying to limit some of the typical risks associated with early stage stocks. This article...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) Could Be 19% Undervalued After REVEAL Study Enrollment Milestone

Ionis Pharmaceuticals (IONS) stock is in focus after the company completed enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL study of obudanersen for Angelman syndrome, a rare neurodevelopmental disorder. See our latest analysis for Ionis Pharmaceuticals. The recent pediatric cohort milestone for obudanersen comes on top of an eventful few weeks for Ionis Pharmaceuticals, including FDA approval of TRYNGOLZA and a new zilganersen licensing deal. During this period the...
NYSE:RNR
NYSE:RNRInsurance

RenaissanceRe Holdings (RNR) Faces An Index Exit As Fair Value Stays In Focus

Index removal puts RenaissanceRe Holdings in focus RenaissanceRe Holdings (RNR) has come into focus after being removed from the Russell 1000 Dynamic Index, a technical event that can prompt mechanical selling and reshuffling among index-linked investors. This index exit sits alongside an upcoming second quarter 2026 earnings release and conference call in late July, giving investors two near term reference points as they reassess how RenaissanceRe Holdings fits within their portfolios. See...
NYSE:HIG
NYSE:HIGInsurance

Hartford Insurance Group (HIG) Faces Earnings Test Following Profit Pressure And A Modest Undervalued View

Hartford Insurance Group (HIG) is back in focus as investors look ahead to its July 23 second-quarter earnings, with expectations for lower profit and rising cost pressures keeping sentiment cautious. See our latest analysis for Hartford Insurance Group. The recent rise in Hartford Insurance Group's share price, including a 1-day share price return of 2.96% to $137.85 and a 1-year total shareholder return of 13.56%, suggests momentum has been rebuilding even as investors weigh upcoming...
NYSE:CFG
NYSE:CFGBanks

Citizens Financial Group (CFG) Could Be 5% Below Fair Value On Russell Index Inclusion

Citizens Financial Group added to Russell defensive indexes Citizens Financial Group (CFG) was recently added to both the Russell 1000 Defensive Index and the Russell 1000 Value Defensive Index, a shift that can influence how index linked funds and benchmarked portfolios treat the stock. See our latest analysis for Citizens Financial Group. Citizens Financial Group shares have climbed in recent months, with a 30 day share price return of 10.94% and year to date share price return of 19.52%,...
NasdaqGS:RUSH.A
NasdaqGS:RUSH.ATrade Distributors

Is Rush Enterprises (RUSH.A) Undervalued On Russell Index Deletions?

Rush Enterprises (RUSH.A) has been removed from multiple Russell value indices, including the Russell 2000, 2500 and 3000 value benchmarks, prompting fresh attention on how index driven flows might affect the stock. See our latest analysis for Rush Enterprises. Despite being removed from several Russell value indices, Rush Enterprises’ recent trading has held up, with a 9.16% 1 month share price return and a 35.26% year to date share price return, alongside a 166.06% 5 year total shareholder...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Joins Russell 1000 On A Valuation Story Still Open To Debate

Index reshuffle puts Modine Manufacturing stock on more investor radars Modine Manufacturing (MOD) has just been added to several Russell indices, including the Russell 1000 and Russell Midcap, while exiting the Russell 2000 suite, a reshuffle that can influence how institutional investors approach the stock. See our latest analysis for Modine Manufacturing. Despite the index reshuffle putting Modine Manufacturing in front of more institutional buyers, the stock has recently given back some...
NYSE:URI
NYSE:URITrade Distributors

What United Rentals (URI)'s Addition to Multiple Russell Growth Indices Means For Shareholders

In late June 2026, United Rentals, Inc. (NYSE: URI) was added to several Russell Growth benchmarks, including the Russell 1000 Growth, Russell 3000 Growth, Russell 3000E Growth and Russell Midcap Growth, potentially broadening its exposure to growth-focused institutional investors. This index inclusion comes as United Rentals is emphasizing equipment rental demand, infrastructure-linked activity and cost discipline, which together could enhance how the market views its growth profile within...
NYSE:GRDN
NYSE:GRDNHealthcare

How Investors Are Reacting To Guardian Pharmacy Services (GRDN) Russell 2000 Defensive Inclusion and CFO Shift

In late June 2026, Guardian Pharmacy Services, Inc. (NYSE:GRDN) was added to both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, while also announcing that long-serving CFO David Morris will become Chief Operating Officer and Senior Vice President of Finance Will Mudd will step up as CFO from July 1, 2026. These index inclusions, alongside a planned leadership transition that keeps experienced insiders in key roles, highlight Guardian’s growing profile among...